BioSig Technologies appoints Gregory Cash to Board of Directors as CEO and President

– CANADA, ON / USA, CA – BioSig Technologies, a company that has developed and is commercializing its proprietary PURE EP™ technology platform designed to significantly improve the clinical value of cardiac recordings in the electrophysiology (EP) field, today announced it has appointed Gregory D.…